Oubari, S., Hegenbart, U., Schoder, R., Steinhardt, M., Papathanasiou, M., Rassaf, T., Thimm, A., Hagenacker, T., Naser, E., Duhrsen, U., Reinhardt, H. C., Kortum, M., Agis, H., Schonland, S. and Carpinteiro, A. (2024) “Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival”, Haematologica. Pavia, Italy, 109(1), pp. 220-230. doi: 10.3324/haematol.2023.283325.